CoChat

Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have become a powerful tool for human disease modeling and therapeutic testing. However, their use remains limited by their immaturity and heterogeneity. To characterize the source of this heterogeneity, we applied complementary single-cell RNA-seq and bulk RNA-seq technologies over time during hiPSC cardiac differentiation and in the adult heart. Using integrated transcriptomic and splicing analysis, more than half a dozen distinct single-cell populations were observed, several of which were coincident at a single time-point, day 30 of differentiation. To dissect the role of distinct cardiac transcriptional regulators associated with each cell population, we systematically tested the effect of a gain or loss of three transcription factors (NR2F2, TBX5, and HEY2), using CRISPR genome editing and ChIP-seq, in conjunction with patch clamp, calcium imaging, and CyTOF analysis. These targets, data, and integrative genomics analysis methods provide a powerful platform for understanding in vitro cellular heterogeneity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-07333-4

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Identification of hiPSC-CM subpopulations by single-cell RNA-seq. a Integrative analytical workflow for identifying distinct cellular populations from single-cell RNA-seq analyses. Associated signatures can subsequently be further interrogated using orthogonal single-cell and bulk techniques (genome editing, ChIP-seq targets, overexpression models, changes at the protein level) and functional assays (calcium handling, patch-clamp). b A monolayer cardiomyocyte differentiation protocol was used to assess how single-cell populations change over time. Single-cell RNA-seq was performed on day 0, day 5, day 14, and day 45 of differentiation and 10,376 cell states identified using the software ICGS and Seurat-CCA. c A t-SNE plot was generated using AltAnalyze to visualize the expression of ICGS associated markers during the different days of differentiation. Twenty distinct cell populations were observed and could be attributed to populations representing pluripotent stem cells (PSC), definitive endoderm (DE), mesoderm (MESO), ectoderm (ECTO), stromal, neural crest (NC), endothelial cells, and early, mid or late cardiomyocyte progenitors
Fig. 1 Identification of hiPSC-CM subpopulations by single-cell RNA-seq. a Integrative analytical workflow for identifying distinct cellular populations from single-cell RNA-seq analyses. Associated signatures can subsequently be further interrogated using orthogonal single-cell and bulk techniques (genome editing, ChIP-seq targets, overexpression models, changes at the protein level) and functional assays (calcium handling, patch-clamp). b A monolayer cardiomyocyte differentiation protocol was used to assess how single-cell populations change over time. Single-cell RNA-seq was performed on day 0, day 5, day 14, and day 45 of differentiation and 10,376 cell states identified using the software ICGS and Seurat-CCA. c A t-SNE plot was generated using AltAnalyze to visualize the expression of ICGS associated markers during the different days of differentiation. Twenty distinct cell populations were observed and could be attributed to populations representing pluripotent stem cells (PSC), definitive endoderm (DE), mesoderm (MESO), ectoderm (ECTO), stromal, neural crest (NC), endothelial cells, and early, mid or late cardiomyocyte progenitorsCC BY · PubMed Central
Fig. 2 Single-cell RNA-seq identified subpopulations of cardiomyocytes. a Late stage cardiomyocytes (4,689 cells with TNNT2 and ACTC1 expression from day 14 and day 45) were further resolved using ICGS to identify subpopulations of cardiomyocytes. Associated t-SNE cell populations were colored by day of differentiation, as well as by cluster identified (markers within each cluster beside each cluster). b Six cardiomyocyte populations were identified representing subpopulations of cardiomyocytes in early proliferative stages (Cluster 4, 5) expressing cyclins, mid-cardiomyocyte stage (Cluster 2, 3) expressing HAND1, and more mature cardiomyocytes (Cluster 0, 1) expressing sarcomeric (MYH6, MYL2, TNNT2, MYBPC3) and calcium handling genes (RYR2, PLN). c Single cells from day 30 of differentiation were profiled using an independent technology (Fluidigm C1) to resolve coincident mid-to-late state differentiation heterogeneity. Genes associated with distinct observed cell populations identified by the algorithm MarkerFinder are shown. Factors with defining expression in each of the HOPACH clustered populations are shown (SF1, ISL1, JARID2, TBX5, MYL2/HEY2, and HOPX). Two major groups in hiPSC-CMs were observed to express either NR2F2 or MYL2/HEY2. Within each group, identified heart developmental regulators were identified using the software GO-Elite (left panel)
Fig. 2 Single-cell RNA-seq identified subpopulations of cardiomyocytes. a Late stage cardiomyocytes (4,689 cells with TNNT2 and ACTC1 expression from day 14 and day 45) were further resolved using ICGS to identify subpopulations of cardiomyocytes. Associated t-SNE cell populations were colored by day of differentiation, as well as by cluster identified (markers within each cluster beside each cluster). b Six cardiomyocyte populations were identified representing subpopulations of cardiomyocytes in early proliferative stages (Cluster 4, 5) expressing cyclins, mid-cardiomyocyte stage (Cluster 2, 3) expressing HAND1, and more mature cardiomyocytes (Cluster 0, 1) expressing sarcomeric (MYH6, MYL2, TNNT2, MYBPC3) and calcium handling genes (RYR2, PLN). c Single cells from day 30 of differentiation were profiled using an independent technology (Fluidigm C1) to resolve coincident mid-to-late state differentiation heterogeneity. Genes associated with distinct observed cell populations identified by the algorithm MarkerFinder are shown. Factors with defining expression in each of the HOPACH clustered populations are shown (SF1, ISL1, JARID2, TBX5, MYL2/HEY2, and HOPX). Two major groups in hiPSC-CMs were observed to express either NR2F2 or MYL2/HEY2. Within each group, identified heart developmental regulators were identified using the software GO-Elite (left panel)CC BY · PubMed Central
Fig. 3 Transcriptome interactions between key transcription factors that regulate hiPSC-CM populations. ChIP-seq was performed on transcription factors (NR2F2, TBX5, and HEY2) enriched within three hiPSC-CM populations. a ChIP-seq peak density demonstrates enrichment of the ChIP-seq signal around the transcriptional start sites (TSS). b GO biological functions were graphed corresponding to peaks called within each ChIP-seq dataset (GREAT analysis, hypergeometric test, p < 0.05). NR2F2 was highly enriched for terms within the nervous system, TBX5 for cardiac tissue, and HEY2 for neural and enteric terms. c Venn diagram demonstrates the number of unique and common genes called (using HOMER) within each ChIP-seq dataset. d Coverage of the reads demonstrating a peak near the MYL2 locus in the TBX5 and HEY2 ChIP-seq datasets, but not the NR2F2 dataset. e RNA-seq was performed on cardiomyocytes from each gene-edited line [NR2F2GE (NR2F2GE1 and NR2F2GE2 lines), HEY2GE (HEY2GE1 and HEY2GE2), and TBX5GE (TBX5GE1 and TBX5GE2)], as well as cardiomyocytes over expressing NR2F2 (NR2F2OE), TBX5 (TBX5OE) and HEY2 (HEY2OE). Biological terms associated with genes significantly different (GO-Elite algorithm AltAnalyze) between these lines were annotated (left panel–blue text), as well as the corresponding ChIP-seq peaks identified (right panel). Gene sets associated with each of the single-cell populations from Fig. 1b are highlighted in orange. Genes associated with the enriched GO terms and single-cell populations are displayed to the right of the heatmap. f GO biological analysis was performed on significant genes upregulated or downregulated in hiPSC-CMs overexpressing NR2F2, TBX5, or HEY2 with corresponding NR2F2, TBX5, or HEY2 gene-edited lines. g Interactions among genes regulated by NR2F2, TBX5, and HEY2 were visualized by combining the significant genes called within each NR2F2GE1, TBX5GE1, and HEY2GE1 with genes called within each ChIP-seq dataset. Nodes (blue circles) represent individual genes and the links represent the genes that interact with each transcription factor. Red indicates an upregulation and green represents a downregulation observed in the RNA-seq of each gene-edited line. h ChIP-seq/RNA-seq interactions using a selected set of cardiac-specific genes. MYL2 is highlighted to be positively regulated by TBX5 and HEY2 expression
Fig. 3 Transcriptome interactions between key transcription factors that regulate hiPSC-CM populations. ChIP-seq was performed on transcription factors (NR2F2, TBX5, and HEY2) enriched within three hiPSC-CM populations. a ChIP-seq peak density demonstrates enrichment of the ChIP-seq signal around the transcriptional start sites (TSS). b GO biological functions were graphed corresponding to peaks called within each ChIP-seq dataset (GREAT analysis, hypergeometric test, p < 0.05). NR2F2 was highly enriched for terms within the nervous system, TBX5 for cardiac tissue, and HEY2 for neural and enteric terms. c Venn diagram demonstrates the number of unique and common genes called (using HOMER) within each ChIP-seq dataset. d Coverage of the reads demonstrating a peak near the MYL2 locus in the TBX5 and HEY2 ChIP-seq datasets, but not the NR2F2 dataset. e RNA-seq was performed on cardiomyocytes from each gene-edited line [NR2F2GE (NR2F2GE1 and NR2F2GE2 lines), HEY2GE (HEY2GE1 and HEY2GE2), and TBX5GE (TBX5GE1 and TBX5GE2)], as well as cardiomyocytes over expressing NR2F2 (NR2F2OE), TBX5 (TBX5OE) and HEY2 (HEY2OE). Biological terms associated with genes significantly different (GO-Elite algorithm AltAnalyze) between these lines were annotated (left panel–blue text), as well as the corresponding ChIP-seq peaks identified (right panel). Gene sets associated with each of the single-cell populations from Fig. 1b are highlighted in orange. Genes associated with the enriched GO terms and single-cell populations are displayed to the right of the heatmap. f GO biological analysis was performed on significant genes upregulated or downregulated in hiPSC-CMs overexpressing NR2F2, TBX5, or HEY2 with corresponding NR2F2, TBX5, or HEY2 gene-edited lines. g Interactions among genes regulated by NR2F2, TBX5, and HEY2 were visualized by combining the significant genes called within each NR2F2GE1, TBX5GE1, and HEY2GE1 with genes called within each ChIP-seq dataset. Nodes (blue circles) represent individual genes and the links represent the genes that interact with each transcription factor. Red indicates an upregulation and green represents a downregulation observed in the RNA-seq of each gene-edited line. h ChIP-seq/RNA-seq interactions using a selected set of cardiac-specific genes. MYL2 is highlighted to be positively regulated by TBX5 and HEY2 expressionCC BY · PubMed Central
Fig. 4 NR2F2, TBX5, and HEY2 influence the electrophysiological properties of hiPSC-CM lines. a Representative traces of calcium imaging on hiPSC-CMs cultured for 14, 30, or 90 days in culture; over time, mature hiPSC-CMs presented a higher baseline ratio, peak ratio amplitude, maximum rising rate and lower transient duration 50. b Calcium imaging was performed on control (day 30-40) and each gene-edited line (day 30–40) to assess the calcium handling ability when NR2F2, TBX5, and HEY2 were disrupted. In comparison to control hiPSC-CMs, HEY2 lines displayed a significantly lower maximum rising rate and amplitude. c Representative patch clamp electrophysiological recordings for each gene-edited line. d Action potential parameters for 22 control, 35 NR2F2GE, 36 TBX5GE, and 34 HEY2GE hiPSC-CMs at day 30-40 were quantified for either ventricular-like or atrial-like action potentials. Significantly lower maximum rising rate (dv/dtmax), maximum diastolic potential (MDP), and action potential amplitude (APA) values were observed in the HEY2GE line when compared to control lines. Increase in action potential amplitude (APD) 50 and APD90 was observed in the ventricular-like NR2F2GE line. e The proportions of atrial-like, ventricular-like, and nodal-like action potentials were quantified within each gene-edited line. Slightly more ventricular-like action potentials were found in the NR2F2GE line, whereas a large proportion of atrial-like action potentials were observed in the HEY2GE line. Lines between bars represent p < 0.05 between groups using a one-way ANOVA
Fig. 4 NR2F2, TBX5, and HEY2 influence the electrophysiological properties of hiPSC-CM lines. a Representative traces of calcium imaging on hiPSC-CMs cultured for 14, 30, or 90 days in culture; over time, mature hiPSC-CMs presented a higher baseline ratio, peak ratio amplitude, maximum rising rate and lower transient duration 50. b Calcium imaging was performed on control (day 30-40) and each gene-edited line (day 30–40) to assess the calcium handling ability when NR2F2, TBX5, and HEY2 were disrupted. In comparison to control hiPSC-CMs, HEY2 lines displayed a significantly lower maximum rising rate and amplitude. c Representative patch clamp electrophysiological recordings for each gene-edited line. d Action potential parameters for 22 control, 35 NR2F2GE, 36 TBX5GE, and 34 HEY2GE hiPSC-CMs at day 30-40 were quantified for either ventricular-like or atrial-like action potentials. Significantly lower maximum rising rate (dv/dtmax), maximum diastolic potential (MDP), and action potential amplitude (APA) values were observed in the HEY2GE line when compared to control lines. Increase in action potential amplitude (APD) 50 and APD90 was observed in the ventricular-like NR2F2GE line. e The proportions of atrial-like, ventricular-like, and nodal-like action potentials were quantified within each gene-edited line. Slightly more ventricular-like action potentials were found in the NR2F2GE line, whereas a large proportion of atrial-like action potentials were observed in the HEY2GE line. Lines between bars represent p < 0.05 between groups using a one-way ANOVACC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 210

Metadata

Authors
Churko, J. M., Garg, P., Treutlein, B., Venkatasubramanian, M., Wu, H., Lee, J., Wessells, Q. N., Chen, S.-Y., Chen, W.-Y., Chetal, K., Mantalas, G., Neff, N., Jabart, E., Sharma, A., Nolan, G. P., Salomonis, N., & Wu, J. C.
Affiliations
  • University of Arizona (US)
  • Stanford Medicine (US)
  • Stanford University (US)
  • Cincinnati Children's Hospital Medical Center (US)
Corresponding author
  • Churko, Jared M.
  • Salomonis, Nathan
  • Wu, Joseph C.
Venue
Nature Communications
Published
2018-11-21
Volume
9
Issue
1
Pages
4906-4906
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2901182248
Cited by
207
References
54
Citations by year
2026: 18 · 2025: 20 · 2024: 30 · 2023: 28 · 2022: 34 · 2021: 24 · 2020: 36 · 2019: 17
FWCI
6.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (TRAN4-09884, NIH-R01)
  • National Heart, Lung, and Blood Institute (R01HL123968, K99HL128906, R01HL128170, R00HL128906, R01HL141371, R01HL141851, R01HL130020)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
human induced pluripotent stem cell-derived cardiomyocytes, cardiac differentiation, cellular heterogeneity, NR2F2, TBX5, Hey2, single-cell RNA sequencing, cardiomyocyte maturation, ChIP-seq, calcium imaging, mass cytometry
MeSH terms
Action Potentials, Cell Differentiation, Humans, Repressor Proteins, Sequence Analysis, RNA, Genetic Heterogeneity, Calcium Signaling, T-Box Domain Proteins, Myocytes, Cardiac, Basic Helix-Loop-Helix Proteins, COUP Transcription Factor II, Induced Pluripotent Stem Cells, Single-Cell Analysis, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis. https://app.cochat.ai/papers/10.1038/s41467-018-07333-4
The paper
Churko, J. M., Garg, P., Treutlein, B., Venkatasubramanian, M., Wu, H., Lee, J., Wessells, Q. N., Chen, S.-Y., Chen, W.-Y., Chetal, K., Mantalas, G., Neff, N., Jabart, E., Sharma, A., Nolan, G. P., Salomonis, N., & Wu, J. C. (2018). Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis. Nature Communications. https://doi.org/10.1038/s41467-018-07333-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.